TEVA
Teva Pharma Industries Ltd
36.50$
-0.6%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +15.8% | -14.3% | +9.0% | +4.0% | -2.4% | -8.0% | +7.3% | +7.3% | +5.2% | -15.5% | +4.0% | – | |
| – | +2.1% | +0.3% | +4.5% | +2.0% | -3.4% | -4.5% | +3.0% | +4.9% | -5.5% | -2.2% | -1.1% | – | |
| – | +30.5% | -26.7% | +14.3% | +6.1% | -1.3% | -11.5% | +12.0% | +9.6% | +15.3% | -25.8% | +9.2% | – | |
| – | -7.5% | +3.4% | +11.2% | -10.8% | +12.9% | -8.9% | -1.2% | +4.9% | +4.3% | -16.9% | +12.6% | – | |
| – | +9.0% | -4.8% | +1.8% | +5.3% | +1.3% | -1.7% | +2.7% | +3.9% | +15.8% | -17.2% | +4.3% | – | |
| – | +10.2% | +19.8% | +2.0% | +8.4% | -2.3% | -36.8% | +21.3% | -13.7% | +65.6% | -44.0% | +52.0% | – | |
| – | +119.8% | -128.8% | – | – | – | – | -12.3% | +93.8% | -66.0% | +117.3% | -77.1% | – | |
| – | -7.1% | -3.8% | -3.6% | +12.9% | +180.5% | -70.5% | -9.8% | +3.0% | +39.7% | -31.2% | -0.5% | – | |
| – | +693.8% | -192.7% | – | – | – | – | -30.6% | +217.6% | -86.0% | +379.1% | -204.4% | – | |
| – | – | -226.8% | – | -89.0% | -59.4% | +164.3% | -205.4% | – | -282.2% | – | +80.6% | – | |
| – | +571.0% | -130.0% | – | – | – | – | +31.8% | +53.5% | +10.9% | -23.1% | -256.1% | – | |
| – | +141.9% | -96.4% | +347.3% | -15.9% | +461.4% | -18.0% | -31.1% | +68.0% | -42.8% | +38.8% | -102.2% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.